Nestlé Health Science (NHSc) announced today an investment in Before Brands, specialists in early childhood allergy prevention. With its significant minority stake, NHSc has acquired the exclusive licensing rights to Before Brands' products outside the United States and also has an option to purchase all remaining equity in Before Brands in the future.
Before Brands is the inventor of the SpoonfulOneTM line, the most advanced childhood nutritional products available to reduce food allergy development risk with 16 key allergens – more than 90% of foods associated with global food allergies and more than any other brand on the market. The core technology is based on research and intellectual property licensed from Stanford University, training the child’s immune system through consistent feeding over months to years.
"This investment enhances our growing business with a new dimension: allergy prevention," said Greg Behar, CEO of Nestlé Health Science. "The prevalence of food allergies among children is increasing, however, studies have shown that consistently exposing children at a very early age to a potential food allergen can reduce the development of an allergy to that food by up to 80 percent. It would be very difficult for parents to achieve this kind of consistent immune-system training to 16 different allergens on their own; SpoonfulOneTM is a convenient and natural solution that fits with the Nestlé Health Science mission of healthier lives through nutrition."
"With Nestlé Health Science, we have secured the ideal partner so that we may advance our mission to help families around the world benefit from SpoonfulOne’s advanced protein science and the new recommendations that advocate proactive, long-term feeding strategies to reduce food allergy development risk," said Ashley Dombkowski, Ph.D., co-founder and CEO of Before Brands. "Their expertise and global footprint will allow us to accelerate education, commercialization, and distribution activities globally."
Read the full press release